Clinical Trials Browser

OTHER × Advanced Tumors × Clear all

NCT06314087 2025-03-25

Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE)

Phase 2 Recruiting

Advanced Tumors

NCT05061628 2021-09-29

The Recombinant Humanized Anti-TIGIT Monoclonal Antibody (JS006) Monotherapy and in Combination With Toripalimab in Patients With Advanced Tumor

Phase 1 Unknown

Advanced Tumors